Evidence map›Paper›PMID 30992671›Full record

ArticleOncoTargets and therapy2019

1,25-Dihydroxyvitamin D

Ye Zhao, Liang-Liang Cai, Hui-Ling Wang, Xiao-Juan Shi, Hui-Ming Ye, Ping Song, Bao-Qi Huang, Chi-Meng Tzeng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Identification of hsa-miR-1275 as a Novel Biomarker TargetingMolecular therapy. Methods & clinical development · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ye ZhaoSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211800, People's Republic of China, tzengchimeng@njtech.edu.cn.
Liang-Liang CaiTranslational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361005, People's Republic of China.
Hui-Ling WangSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211800, People's Republic of China, tzengchimeng@njtech.edu.cn.
Xiao-Juan ShiSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211800, People's Republic of China, tzengchimeng@njtech.edu.cn.
Hui-Ming YeDepartment of Clinical Laboratory, Zhongshan Hospital Xiamen University, Xiamen 361004, People's Republic of China.
Ping SongCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211800, People's Republic of China.
Bao-Qi HuangCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211800, People's Republic of China.
Chi-Meng TzengSchool of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 211800, People's Republic of China, tzengchimeng@njtech.edu.cn.
Nanjing Tech University · CNXiamen University · CNZhongshan Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVitamin D

methodsThe Roche Elecsys platform was applied in retrospective studies to detect the role of 25-hydroxylvitamin D

resultsHere we show that low concentration of 1, 25-dihydroxyvitamin D

conclusionIn combination with the data from clinical research, bioinformatics analysis and experimental verification, we propose that 1, 25-hydroxylvitamin D

Indexed as

125-dihydroxyvitamin D3BMP3gastric cancerpromoter methylation

Identifiers

PMID30992671
PMCPMC6445188
OpenAlexW2923307612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.